Cytelabs launches DISH testing, an US FDA approved technique for breast cancer with reduced waiting time for treatment access

“Traditionally, these equivocal cases are subjected to fluorescent in situ hybridization (FISH) technique for the final status. This test mandatorily requires fluorescent microscope and trained personnel, which is not easily available in all Indian hospitals dealing with cancer cases. Hence this necessitates outsourcing this test to a specialized centre either within the city or outside,” said Dr Gangoli.

Furthermore, the test itself is time-consuming, invariably leading to a waiting period of a week to 12 days, depending on the work load and other variables. DISH, on the other hand, provides the final HER2 status report within 24-48 hours. What’s more, it is available at the same price point as FISH, she said.

Unlike FISH though, DISH is interpreted through the usual binocular, non-fluorescent microscope on the same biopsy tissue, through a different technique. The slide preparation albeit is done on an automated platform, Ventana, in accordance with the standard guidelines. In addition, DISH also enables the pathologist to visualise and thereby select the individual tumour cells better, which is not possible in FISH.

Currently, Cytelabs provides easy access to high-quality cancer diagnostic services to oncologists and patients across 65 partner hospitals in Karnataka, Andhra Pradesh, and Telangana. As an exclusive tissue pathology lab, with an accent on cancer pathology, it provides accessible, affordable and accurate evidence-based tissue pathology reports in the shortest possible turnaround time so that the right treatment can ensue seamlessly.

With highly trained personnel, Cytelabs also performs specialized tests, such as immunohistochemistry (IHC), integral to cancer diagnosis, using the automated Ventana platform for diagnostic and prognostic purposes. The focused expertise allows Cytelabs to deliver precise oncopathological services that greatly contribute to improved patient outcomes.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!